May 3, 2018 15:00 UTC Atreca Announces Publication of HIV Research in Cell Research Findings Promise New Avenues for Anti-Viral Therapeutic Development REDWOOD CITY, Calif.--( BUSINESS WIRE )-- Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today publication of research focused on HIV that was enabled by Atreca’s